Cantaert Tineke, Schickel Jean-Nicolas, Bannock Jason M, Ng Yen-Shing, Massad Christopher, Delmotte Fabien R, Yamakawa Natsuko, Glauzy Salome, Chamberlain Nicolas, Kinnunen Tuure, Menard Laurence, Lavoie Aubert, Walter Jolan E, Notarangelo Luigi D, Bruneau Julie, Al-Herz Waleed, Kilic Sara Sebnem, Ochs Hans D, Cunningham-Rundles Charlotte, van der Burg Mirjam, Kuijpers Taco W, Kracker Sven, Kaneko Hideo, Sekinaka Yujin, Nonoyama Shigeaki, Durandy Anne, Meffre Eric
J Clin Invest. 2016 Nov 1;126(11):4289-4302. doi: 10.1172/JCI84645. Epub 2016 Oct 4.
Patients with mutations in AICDA, which encodes activation-induced cytidine deaminase (AID), display an impaired peripheral B cell tolerance. AID mediates class-switch recombination (CSR) and somatic hypermutation (SHM) in B cells, but the mechanism by which AID prevents the accumulation of autoreactive B cells in blood is unclear. Here, we analyzed B cell tolerance in AID-deficient patients, patients with autosomal dominant AID mutations (AD-AID), asymptomatic AICDA heterozygotes (AID+/-), and patients with uracil N-glycosylase (UNG) deficiency, which impairs CSR but not SHM. The low frequency of autoreactive mature naive B cells in UNG-deficient patients resembled that of healthy subjects, revealing that impaired CSR does not interfere with the peripheral B cell tolerance checkpoint. In contrast, we observed decreased frequencies of SHM in memory B cells from AD-AID patients and AID+/- subjects, who were unable to prevent the accumulation of autoreactive mature naive B cells. In addition, the individuals with AICDA mutations, but not UNG-deficient patients, displayed Tregs with defective suppressive capacity that correlated with increases in circulating T follicular helper cells and enhanced cytokine production. We conclude that SHM, but not CSR, regulates peripheral B cell tolerance through the production of mutated antibodies that clear antigens and prevent sustained interleukin secretions that interfere with Treg function.
编码激活诱导胞苷脱氨酶(AID)的AICDA发生突变的患者,其外周B细胞耐受性受损。AID介导B细胞中的类别转换重组(CSR)和体细胞高频突变(SHM),但AID阻止自身反应性B细胞在血液中积累的机制尚不清楚。在此,我们分析了AID缺陷患者、常染色体显性AID突变(AD - AID)患者、无症状AICDA杂合子(AID+/-)以及尿嘧啶N - 糖基化酶(UNG)缺陷患者(其损害CSR但不损害SHM)的B细胞耐受性。UNG缺陷患者中自身反应性成熟幼稚B细胞的低频与健康受试者相似,表明受损的CSR并不干扰外周B细胞耐受性检查点。相反,我们观察到AD - AID患者和AID+/-受试者的记忆B细胞中SHM频率降低,他们无法阻止自身反应性成熟幼稚B细胞的积累。此外,具有AICDA突变的个体,而非UNG缺陷患者,表现出调节性T细胞(Tregs)抑制能力缺陷,这与循环滤泡辅助性T细胞增加和细胞因子产生增强相关。我们得出结论,SHM而非CSR通过产生清除抗原并防止干扰Treg功能的持续白细胞介素分泌来调节外周B细胞耐受性。